FAQs Is hair loss a known side effect of semaglutide or tirzepatide
We excluded individuals prescribed with GLP-1 RAs or SGLT-2 inhibitors before index date in the GLP-1 RA vs
Clinical Trial Results SURMOUNT-1 trial: Average weight loss of ~20% of total body weight
Diabetes Care 35 , 12251231 (2012)
For inflammation Chronic low-grade inflammation, sometimes called inflammaging, contributes to fatigue, joint pain, insulin resistance, and cognitive changes
Author contributions All authors contributed to conception and design, analysis and interpretation of the evidence, drafting of the manuscript, finalization of the manuscript, and the decision to submit to publication